Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-21-000613
Filing Date
2021-07-02
Accepted
2021-07-02 18:08:04
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4572
  Complete submission text file 0001192482-21-000613.txt   6038
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Schmidt William K (Reporting) CIK: 0001301122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38306 | Film No.: 211071857

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Issuer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations